KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 37 days ( 0 % )
Last Price $0.0748 0 %
High/ Low $0.0748 - $0.0748 0%
Chg 7 Days N/A $0.0748 $0.0748
Chg 30 Days N/A $0.0748 $0.0748
Chg 12 mos -81.99 % $0.415 $0.0748
Trend - 3 mos -13.45 % Width: 41.87 %
Trend - 12 mos -59.06 % Width: 239.37 %
Pred. range - 3 mos $0.0537 - $0.0762 -28.16 % - 1.92 %
Pred. range - 12 mos N/A - $0.164 -100.00 % - 118.88 %
Short MA avg 3 mos Buy Feb 26, 2024 - 44 days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Feb 26, 2024 - 44 days
Long MA avg 12 mos Buy Sep 21, 2023 - 151 days
Short/Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Pivot Short Buy Mar 04, 2024 - 39 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem ce... BLCM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT